Fig. 7: The comparison of pathway-based super signatures with existing signatures. | Nature Communications

Fig. 7: The comparison of pathway-based super signatures with existing signatures.

From: Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma

Fig. 7

a The performance of pathway-based super signature (PASS-PRE) and time-response interaction pathway-based super signatures for pre-treatment samples (TimeANLS-PRE) in comparison with publicly existing signatures. b The performance of pathway-based super signature (PASS-ON) and time-response interaction pathway-based super signatures for on-treatment samples (TimeANLS-ON) with existing signatures. Each cohort’s sample number were showed in the legend. The mean value and standard deviation of AUCs were showed as error bar. Source data are provided as a Source Data file.

Back to article page